Novavax Inc expected to post a loss of 39 cents a share - Earnings Preview

Novavax

04/08/2026 15:37

Novavax Inc NVAX.OQ NVAX.O is expected to  show a fall in quarterly revenue when it reports  results on August 6 for the period ending June 30 2026
The Gaithersburg Maryland-based  company is expected to report a 78.1% decrease in revenue to $52.513 million from $239.24 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Novavax Inc is for a loss of 39 cents per share. 
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and 3 "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Novavax Inc is $16.00, about 115.9% above its last closing price of $7.41
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.22
-0.23
-0.06
Beat
73.9
Dec. 31 2026
-0.49
-0.49
0.11
Beat
122.6
Sep. 30 2025
-1.30
-1.19
-1.25
Missed
-5.4​
Jun. 30 2025
-0.24
-0.08
0.62
Beat
842.5
​​Mar. 31 2025
0.81
0.71
2.93
Beat
315
Dec. 31 2024
-0.37
-0.51
-0.83
Missed
-61.5​
Sep. 30 2024
-0.81
-0.79
-0.76
Beat
4
Jun. 30 2024
1.65
1.64
0.99
Missed
-39.5
This summary was machine generated August 4 at 14:37 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)